Boston Scientific (BSX) Total Liabilities (2009 - 2026)

Boston Scientific has disclosed Total Liabilities across 18 years of filings, most recently posting $18.2 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $18.2 billion, up 3.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.2 billion (up 3.13% YoY), and the FY2025 annual result was $19.2 billion, up 8.94% from the prior year.
• Total Liabilities came in at $18.2 billion for Q1 2026 at Boston Scientific, down from $19.2 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $37.1 billion in Q2 2024 to a low of $12.1 billion in Q2 2022.
• The 5-year median for Total Liabilities is $19.1 billion (2025), against an average of $23.1 billion.
• Across the five-year window, Total Liabilities sank 61.2% in 2022 and jumped 175.87% in 2023, its largest moves.
• Boston Scientific's Total Liabilities stood at $32.2 billion in 2022, then slumped by 51.53% to $15.6 billion in 2023, then grew by 12.94% to $17.6 billion in 2024, then rose by 8.94% to $19.2 billion in 2025, then retreated by 4.97% to $18.2 billion in 2026.
• The last three Total Liabilities figures came in at $18.2 billion (Q1 2026), $19.2 billion (Q4 2025), and $19.1 billion (Q3 2025), per Business Quant data.